Skip to main content
. 2013 Feb 25;168(6):1456–1470. doi: 10.1111/bph.12043

Figure 6.

Figure 6

Effect of WAY100635 (0.1 mg·kg−1) or SAL administered i.p. on the ability of CBDA (0.1 mg·kg−1 i.p.) to suppress the expression of gaping in rats to a context previously paired with LiCl (a model of anticipatory nausea). Each bar represents the mean number of conditioned gaping responses ± SEM (n = 10). The asterisks indicate a significant difference from the SAL-VEH-treated control animals (**P < 0.01; one-way anova).